Publication:
THE EFFICACY AND DRUG SURVIVAL OF THE BIOSIMILAR INFLIXIMAB (CT-P13) COMPARED TO THE ORIGINAL REFERENCE INFLIXIMAB IN INFLAMMATORY RHEUMATIC DISEASES; RESULTS FROM THE TURKBIO REGISTRY

Simple item page
dc.contributor.authorsUslu, S.; Can, G.; Senel, S.; Dalkilic, E.; Inanc, N.; Akar, S.; Kocaer, S. B.; Birlik, M.; Capar, S.; Akkoc, N.; Onen, F.
dc.date.accessioned2022-03-12T04:21:47Z
dc.date.accessioned2026-01-11T06:00:15Z
dc.date.available2022-03-12T04:21:47Z
dc.date.issued2018-06
dc.identifier.doi10.1136/annrheumdis-2018-eular.6440
dc.identifier.eissn1468-2060
dc.identifier.issn0003-4967
dc.identifier.urihttps://hdl.handle.net/11424/223799
dc.identifier.wosWOS:000444351001026
dc.language.isoeng
dc.publisherBMJ PUBLISHING GROUP
dc.relation.ispartofANNALS OF THE RHEUMATIC DISEASES
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleTHE EFFICACY AND DRUG SURVIVAL OF THE BIOSIMILAR INFLIXIMAB (CT-P13) COMPARED TO THE ORIGINAL REFERENCE INFLIXIMAB IN INFLAMMATORY RHEUMATIC DISEASES; RESULTS FROM THE TURKBIO REGISTRY
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage329
oaire.citation.startPage329
oaire.citation.titleANNALS OF THE RHEUMATIC DISEASES
oaire.citation.volume77

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
168.79 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları